Ranivisio Euroopan unioni - islanti - EMA (European Medicines Agency)

ranivisio

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - augnlækningar - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Tramadol Krka Forðatafla 200 mg Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

tramadol krka forðatafla 200 mg

krka, d.d., novo mesto - tramadolum hýdróklóríð - forðatafla - 200 mg

Brimonidin Bluefish Augndropar, lausn 2 mg/ml Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

brimonidin bluefish augndropar, lausn 2 mg/ml

bluefish pharmaceuticals ab - brimonidinum tartrat - augndropar, lausn - 2 mg/ml

Strefen Honung & Citron (Strefen Körsbär & Mint) Munnholsúði, lausn 16,2 mg/ml Islanti - islanti - LYFJASTOFNUN (Icelandic Medicines Agency)

strefen honung & citron (strefen körsbär & mint) munnholsúði, lausn 16,2 mg/ml

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnholsúði, lausn - 16,2 mg/ml